Cargando…
Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729370/ https://www.ncbi.nlm.nih.gov/pubmed/33313221 http://dx.doi.org/10.21037/atm-20-5026 |
| _version_ | 1783621443150413824 |
|---|---|
| author | Cao, Christopher Guo, Allen Chen, Christopher Zielinski, Rob Bott, Matthew |
| author_facet | Cao, Christopher Guo, Allen Chen, Christopher Zielinski, Rob Bott, Matthew |
| author_sort | Cao, Christopher |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7729370 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77293702020-12-11 Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence Cao, Christopher Guo, Allen Chen, Christopher Zielinski, Rob Bott, Matthew Ann Transl Med Editorial AME Publishing Company 2020-11 /pmc/articles/PMC7729370/ /pubmed/33313221 http://dx.doi.org/10.21037/atm-20-5026 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Cao, Christopher Guo, Allen Chen, Christopher Zielinski, Rob Bott, Matthew Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title | Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title_full | Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title_fullStr | Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title_full_unstemmed | Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title_short | Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| title_sort | neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729370/ https://www.ncbi.nlm.nih.gov/pubmed/33313221 http://dx.doi.org/10.21037/atm-20-5026 |
| work_keys_str_mv | AT caochristopher neoadjuvantimmunotherapyforpatientswithnonsmallcelllungcancercurrentevidence AT guoallen neoadjuvantimmunotherapyforpatientswithnonsmallcelllungcancercurrentevidence AT chenchristopher neoadjuvantimmunotherapyforpatientswithnonsmallcelllungcancercurrentevidence AT zielinskirob neoadjuvantimmunotherapyforpatientswithnonsmallcelllungcancercurrentevidence AT bottmatthew neoadjuvantimmunotherapyforpatientswithnonsmallcelllungcancercurrentevidence |